Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes-Reference-Cited by-同舟云学术

Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes

Published:2008-05-01 Issue:5 Volume:31 Page:930-931
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Fukui Michiaki¹,Tanaka Muhei¹,Kadono Mayuko¹,Imai Saeko²,Hasegawa Goji¹,Yoshikawa Toshikazu¹,Nakamura Naoto¹

Affiliation:

1. Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

2. Department of Clinical Nutrition, Faculty of Comprehensive Rehabilitation, Osaka Prefecture University, Osaka, Japan

Abstract

OBJECTIVE—The aims of this study were to examine if serum prostate-specific antigen (PSA) levels are lower in men with type 2 diabetes compared with those in healthy men and to investigate what factors may be associated with serum PSA levels in men with type 2 diabetes. RESEARCH DESIGN AND METHODS—We compared the serum PSA levels in 224 diabetic men with those in 1,293 healthy men and investigated the relationships between serum PSA levels and various variables. RESULTS—Except for men aged 40–49 years, serum PSA levels were lower in diabetic men than in healthy men. Multiple regression analysis demonstrated that age, BMI, and presence of diabetes were independent determinants of serum PSA level. CONCLUSIONS—Serum PSA levels were lower in diabetic men compared with those in healthy men, which is in line with previous reports that patients with type 2 diabetes are at a decreased risk of prostate cancer.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/31/5/930/598674/zdc00508000930.pdf

Reference9 articles.

1. Everhart J, Wright D: Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA 273:1605–1609, 1995

2. Stricker HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD, Yu H: the relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263–274, 2001

3. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO: Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258–261, 2002

4. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE: Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 161:147–152, 2005

5. Bonovas S, Filioussi K, Tsantes A: Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47:1071–1078, 2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poor Glycemic Control Affecting Screening of Prostate Carcinoma;Cureus;2024-04-21

2. Statins may increase the risk of being diagnosed with prostate cancer;Minerva Urology and Nephrology;2023-10

3. Association between body mass index and hemoglobin A1c with serum prostate-specific antigen level;Saudi Medical Journal;2023-09

4. Association of TyG index with prostate-specific antigen (PSA) in American men: results from NHANES, 2003–2010;Irish Journal of Medical Science (1971 -);2023-06-20

5. Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram;Metabolites;2023-01-09